Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease Read more
World Health Organisation’s Senior Advisor to speak at 21st Annual Superbugs & Superdrugs Conference Read more
Interview Released with Novartis ahead of Pre-Filled Syringes & Injectable Drug Devices Europe 2019 Read more
Octapharma receives Swissmedic approval for fibryga to treat congenital and acquired fibrinogen deficiencies Read more